RELMADA THERAPEUTICS, INC. (RLMD) › Net IncomeRELMADA THERAPEUTICS, INC. (RLMD) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$6.86M2013: -$19.87M2015: -$20.80M2016: -$2.97M2017: -$6.29M2018: -$8.96M2019: -$15.01M2020: -$59.46M2021: -$125.75M2022: -$157.04M2023: -$98.79M2024: -$79.98M2025: -$57.39M-$57.39M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$57.39M+28.3%2024-$79.98M+19.0%2023-$98.79M+37.1%2022-$157.04M-24.9%2021-$125.75M-111.5%2020-$59.46M-296.2%2019-$15.01M-67.5%2018-$8.96M-42.5%2017-$6.29M-111.3%2016-$2.97M+85.7%2015-$20.80M—2013-$19.87M-189.7%2012-$6.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share